Pancreatic cancer drug may hold promise for lung cancer
Digest more
Consuming a sugar-sweetened drink daily could result in a 2.45-fold higher risk of developing gastric cancer, the study found ...
Dayna Mooney chose alternative remedies over the recommendations of her son’s doctors. Was that her right as a parent or a ...
Thyme Care has raised $125 million from investors in a deal doubling the cancer startup's valuation as it tackles critical ...
This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free ...
More and more oncology clinics are being snapped up by hospitals, and it's resulting in much higher bills for those seeking ...
One of the most aggressive types of breast cancer may have a weakness that researchers have managed to exploit.
A new study, described as "hugely encouraging" for patients, has found the majority of breast cancer survivors whose ...
2don MSN
Nearly 1 in 3 young women haven’t had cervical cancer screening. A doctor explains the risks
Cervical cancer screening rates are moving in the wrong direction. A doctor explains who should be screened and when.
A new data cut of a trial pitting ivonescimab, a bispecific antibody, against Merck’s Keytruda showed the new drug helped people live longer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results